Israel’s Magenta Medical (see here previously) reported positive results in a 15-patient trial of its Elevate System. The percutaneous Left Ventricular Assist Device (pLVAD) supports circulation in high-risk percutaneous coronary interventions (HR-PCI).

https://www.prnewswire.com/il/news-releases/magenta-medical-reports-positive-results-for-us-early-feasibility-study-of-elevate-heart-pump-in-providing-temporary-mechanical-circulatory-support-during-high-risk-pci-procedures-301968986.html